Log In
Print this Print this

KRAS Assay

  Manage Alerts
Collapse Summary General Information
Company Cancer Genetics Inc.
DescriptionRT-PCR to detect K-Ras (KRAS) mutations on exons 2, 3 and 4
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose KRAS mutations
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today